Difference between revisions of "Zhang L, et al. PLoS ONE (2016) cited as Ref 295 in DOI: 10.1038/s41392-020-0110-5 (Q9558)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): PLoS ONE, #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | PLoS ONE | ||
| Property / Published In Name String: PLoS ONE / rank | |||
| + | Normal rank | ||
Revision as of 20:36, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zhang L, et al. PLoS ONE (2016) cited as Ref 295 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zhang L
0 references
2016
0 references
PLoS ONE
0 references
